A new treatment for lung scarring due to Covid-19 infection
RT1840 is a repurposed, safe compound, formulated as an inhaled product to directly administer to the lung to prevent/reverse scarring (fibrosis)
Dobbs Ferry,
NY,
United States
$ 500,000
pledged of $ 35,000,000 goal